 DURHAM, N.C., April 26, 2021 GLOBE NEWSWIRE -- Chimerix NASDAQ:CMRX, a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced the appointment of Vicki Vakiener to its Board of Directors, effective immediately. Ms. Vakiener currently serves as Chief Commercial Officer of Epizyme Inc. 